Inventor · disambiguated record
Michele L. R. Heffernan
Also filed as: HEFFERNAN MICHELE · HEFFERNAN MICHELE L R
27 granted patents·10 pending applications·283 citations·filing 2000–2024
96Inventor score
Files withSEPRACOR INC20SUNOVION PHARMACEUTICALS INC10SUMITOMO PHARMA AMERICA INC3HEFFERNAN MICHELE L R2HARDY LARRY WENDELL1
Top patents by PatentIndex Score
37 records- 0195US6645980B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Nov 11, 2003·46 cites·21 claims
- 0294US7615572B2Pyrrole and pyrazole DAAO inhibitorsSEPRACOR INC·Filed 2008·Granted Nov 10, 2009·26 cites·8 claims
- 0393US7579370B2Fused heterocyclesSEPRACOR INC·Filed 2007·Granted Aug 25, 2009·25 cites·15 claims
- 0491US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
- 0591US7166725B2Benzo[d]isoxazol-3-ol DAAO inhibitorsSEPRACOR INC·Filed 2004·Granted Jan 23, 2007·47 cites·3 claims
- 0689US8772301B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofHARDY LARRY WENDELL·Filed 2010·Granted Jul 8, 2014·13 cites·32 claims
- 0789US7884124B2Fluoro-substituted inhibitors of D-amino acid oxidaseSEPRACOR INC·Filed 2007·Granted Feb 8, 2011·9 cites·30 claims
- 0889US7488747B2Pyrrole and pyrazole DAAO inhibitorsSEPRACOR INC·Filed 2004·Granted Feb 10, 2009·28 cites·8 claims
- 0988US6699866B2Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2002·Granted Mar 2, 2004·17 cites·23 claims
- 1088US6677332B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Jan 13, 2004·22 cites·32 claims
- 1187US11491133B2Heteroaryl-isochroman compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·2 cites·57 claims
- 1286US6635661B2Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2001·Granted Oct 21, 2003·16 cites·26 claims
- 1385US7893098B2Pyrrole and pyrazole DAAO inhibitorsSEPRACOR INC·Filed 2009·Granted Feb 22, 2011·6 cites·10 claims
- 1484US7902252B2Inhibitors of D-amino acid oxidaseSEPRACOR INC·Filed 2009·Granted Mar 8, 2011·4 cites·12 claims
- 1581US7129228B2Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2004·Granted Oct 31, 2006·9 cites·28 claims
- 1681US2024409550A1Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 1780US10780074B2Compounds and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·2 cites·55 claims
- 1873US10927124B2Compounds and compositions and uses thereofPGI DRUG DISCOVERY LLC·Filed 2018·Granted Feb 23, 2021·1 cites·26 claims
- 1970US11958862B2Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2021·Granted Apr 16, 2024·0 cites·34 claims
- 2068US10640510B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·0 cites·6 claims
- 2166US10077243B2Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Sep 18, 2018·0 cites·11 claims
- 2266US7087623B2Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2004·Granted Aug 8, 2006·2 cites·20 claims
- 2364US2010029741A1Fused heterocyclesSEPRACOR INC·Filed 2009·Application pending·0 cites
- 2464US2010022612A1Fused heterocyclesSEPRACOR INC·Filed 2009·Application pending·0 cites
- 2563US10196399B2Metabotrophic glutamate receptor 5 modulators and methods use thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·0 cites·9 claims
- 2662US7692019B2Methods for the stereoselective synthesis of substituted piperidinesSEPRACOR INC·Filed 2006·Granted Apr 6, 2010·0 cites·27 claims
- 2762US2019055204A1Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2860US9708331B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·0 cites·15 claims
- 2956US9260452B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Feb 16, 2016·0 cites·18 claims
- 3055US2024158416A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUMITOMO PHARMA AMERICA INC·Filed 2022·Application pending·0 cites
- 3153US2011092559A1Pyrrole and pyrazole daao inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3251US2010120740A1Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidaseSEPRACOR INC·Filed 2009·Application pending·0 cites
- 3350US2008058395A1Fused heterocyclic inhibitors of D-amino acid oxidaseSEPRACOR INC·Filed 2007·Application pending·0 cites
- 3448US2009099248A1Inhibitors of d-amino acid oxidaseSEPRACOR INC·Filed 2008·Application pending·0 cites
- 3541US11186564B2Dual NAV1.2/5HT2a inhibitors for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Nov 30, 2021·0 cites·11 claims
- 3637US2011034434A1Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidaseSEPRACOR INC·Filed 2010·Application pending·0 cites
- 3735US10533000B2Metabotrophic glutamate receptor 5 modulators and methods of use thereofHEFFERNAN MICHELE L R·Filed 2012·Granted Jan 14, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Michele L. R. Heffernan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →